ARK Genomics Revolution

Sitemap

Write

91 followers

Simon Barnett

On Ginkgo Bioworks

This piece represents ARK’s newest form of written content: “Works in Progress (WIP)”. WIP content is a snapshot of our internal research…

Oct 22, 2021

Oct 22, 2021

ARK analyst commentary in the genomics, pharma, synbio, agbio, and other -omics spaces| Disclosure: http://arkinv.st/2rxmMRG

Connect with ARK Genomics Revolution

Editors

Pierce Jamieson

ARK Invest research associate covering ag biotech 🌽 synthetic biology 🦠 and innovation in the multi-omics space | Disclosure: http://arkinv.st/2rxmMRG

Simon Barnett

Director of Life Sciences Research (@ARKInvest) / Focus on Sequencing, Diagnostics, and Comp. Bio (Prev: @JHU_ChemBE) http://ark-invest.com/terms/#twitter

Ali Urman

@ARKinvest Genomics Analyst - love anything immunotherapy, gene editing, stem cell therapy, AI and public health related. Disclosure: http://bit.ly/1C5DBVL

Help

Status

About

Careers

Press

Blog

Privacy

Rules

Terms

Text to speech